NDC 63629-1024-08 - Amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-1024
- Requested NDC
- 63629-1024-08
- Package NDCs from labels
- 63629-1024-2, 63629-1024-3, 63629-1024-5, 63629-1024-6, 63629-1024-8, 63629-1024-08
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-01-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amlodipine besylate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-01-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-1024-2 | Amlodipine besylate | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 63629-1024-3 | Amlodipine besylate | 300 in 1 BOTTLE | TABLET | 300 | 7 | |
| 63629-1024-5 | Amlodipine besylate | 500 in 1 BOTTLE | TABLET | 500 | 7 | |
| 63629-1024-6 | Amlodipine besylate | 60 in 1 BOTTLE | TABLET | 60 | 7 | |
| 63629-1024-8 | Amlodipine besylate | 800 in 1 BOTTLE | TABLET | 800 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-1024 | AMLODIPINE BESYLATE TABLET [BRYANT RANCH PREPACK] | 7 | Current NDC, Legacy NDC, 5 package rows | 20240110_e8958997-f098-44ce-8c21-b7064d1a962e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | c9693ad5-0fa6-4796-b20b-2021d589a132 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | 47114f60-4151-43d4-ac2d-adc49492a679 | 2025-10-15 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ac0dd8fb-ebe1-4d02-bd0d-4f979c6e3608 | 2025-10-15 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 02e233c4-48d1-456d-8fc8-f99a06ef854a | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Quallent Pharmaceuticals Health LLC | c262dedb-1d13-4447-9355-f11e1dbbfb4d | 2025-10-13 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 7b5eb6bd-e953-429e-9280-07da4f7d7f47 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 968c611b-43a7-40f0-9ed3-aa67ee88364b | 2025-10-03 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 6cf5ece4-4d4e-478e-be8f-bd198c6edc5d | 2025-09-29 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 3ce6978a-6ab3-33a9-e063-6294a90a24a1 | 2025-08-21 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine besylate and Olmesartran medoxomil | AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL | Alembic Pharmaceuticals Inc. | 1eb78d80-701d-4766-98c3-feee6790de1a | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Olmesartan medoxomil Amlodipine and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 52c013e1-8c31-4bed-9241-e7845873ebe8 | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | c277f1d8-2ee0-4111-adb6-38998f77dede | 2025-07-18 | Warnings | L11K75P92J |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Direct_Rx | 0c7d1f99-dfe0-7041-e063-6294a90a9705 | 2025-07-11 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | 81d59754-1b36-4f71-aec1-5335b003a96f | 2025-07-01 | Warnings | L11K75P92J |
| olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Slate Run Pharmaceuticals, LLC | a469adff-25a6-4983-b471-60924d920a86 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | 2437a130-d544-6db4-e063-6394a90a0d4d | 2025-06-13 | Warnings, Adverse reactions | 308135 864V2Q084H |
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | e9ecbadb-c548-6fe5-e053-2a95a90a7577 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | d058e426-8786-4fd3-a771-992e4558c135 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Ascend Laboratories, LLC | c1204fbe-d086-43cf-bbaa-efec9cd0487c | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Alembic Pharmaceuticals Inc. | 1346631f-e6db-4c5c-a6af-5aa7b80a011d | 2025-05-23 | Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.